Robert Wienecke, MD
Neurological Surgery · Oklahoma City, OKNPI 1669461000
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $34,011 of the $40,034 with a category attached, or 85.0%. Alphatec Spine, Inc accounts for 85.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2020 at $22,278 and has fallen 99.0% since, to $230 in 2025.
Across 75 payments — averaging $533.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alphatec Spine, Inc$34K
- Medtronic$3K
- Integrity Implants Inc.$2K
- Curiteva, Inc.$230
- Baxter Healthcare$45
- Intrinsic Therapeutics$36
- plus $63 from 3 others
What the payments were for
- Royalty or licence$34,01185%
- Travel & lodging$3,7799%
- Food & beverage$2,2005%
- Gifts$440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alphatec Spine, Inc | 14 | $34,011 |
| Medtronic(2 entities) | 41 | $3,266 |
| Integrity Implants Inc. | 13 | $2,382 |
| Curiteva, Inc. | 1 | $230 |
| Baxter Healthcare | 2 | $45 |
| Intrinsic Therapeutics | 1 | $36 |
| Johnson & Johnson | 1 | $36 |
| AbbVie | 1 | $16 |
| Arteriocyte Medical Systems, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Arsenal Degenerative$28,443
- Arsenal Deformity$11,860
- FlareHawk$2,230
- CD HORIZON SPINAL SYSTEM$1,449
- MAZOR X SYSTEM$897
How this compares
$40,034 in reported general payments places this provider in the 85th percentile of 80 neurological surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methocarbamol | 93 | $719 |
| Gabapentin | 62 | $668 |
| Oxycodone Hcl | 82 | $662 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 46 | $500 |
| Baclofen | 14 | $378 |
| Methylprednisolone | 37 | $220 |
| Cyclobenzaprine Hcl | 21 | $202 |
| Pregabalin | 16 | $198 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $171 |
| Hydromorphone Hcl | 18 | $137 |
| Tizanidine Hcl | 13 | $100 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Oklahoma City
- Brian SnellOklahoma City$3.7M
- Fadi NasrOklahoma City$1.6M
- Robert TibbsOklahoma City$537K
- Michael HahnOklahoma City$267K
- Isaac KarikariOklahoma City$137K
- Joseph CoxOklahoma City$123K
- Hakeem ShakirOklahoma City$63K
- Muhammad JanjuaOklahoma City$33K
- Caple SpenceOklahoma City$31K
- Andrew ConnerOklahoma City$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.